Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality. [electronic resource]
Producer: 20091014Description: 919-29 p. digitalISSN:- 1523-6536
- Adult
- Aged
- Chemoprevention -- methods
- Cohort Studies
- Drug Therapy, Combination
- Female
- Graft vs Host Disease -- drug therapy
- HLA Antigens
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Histocompatibility
- Humans
- Immunosuppressive Agents -- therapeutic use
- Incidence
- Male
- Middle Aged
- Mycophenolic Acid -- administration & dosage
- Outpatients
- Survival Analysis
- Tacrolimus -- administration & dosage
- Transplantation Conditioning -- methods
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.